Location History:
- Pretoria, ZA (2017)
- Zurich, CH (2023)
Company Filing History:
Years Active: 2017-2023
Title: Renier Myburgh: Innovator in Gene Expression Technologies
Introduction
Renier Myburgh is a notable inventor based in Pretoria, South Africa. He has made significant contributions to the field of gene expression technologies, holding 2 patents that focus on innovative methods for gene regulation.
Latest Patents
Myburgh's latest patents include "Micro RNA expression constructs and uses thereof" and "Nucleic acids for down-regulation of gene expression." The first patent relates to miRNA expression constructs designed for the expression of multiple miRNAs, which can be utilized to knock down target gene expression. These constructs may include a promoter element, a spacer sequence, and a miRNA coding sequence, enhancing immune cell function. The second patent provides recombinant nucleic acid molecules that form hairpin structures, which can be used to down-regulate gene expression. This includes a nucleic acid molecule that comprises a flanking and lower stem loop sequence from a mir-16 gene, an antisense target sequence, a mir-30 loop sequence, and a lower stem loop complementary to the mir-16 sequence.
Career Highlights
Throughout his career, Myburgh has worked with prestigious institutions, including the University of Geneva and Les Hôpitaux Universitaires De Genève. His work has significantly advanced the understanding and application of gene expression technologies.
Collaborations
Myburgh has collaborated with notable professionals in his field, including Karl-Heinz Krause and Patrick Salmon. These collaborations have further enriched his research and contributions to gene expression.
Conclusion
Renier Myburgh is a distinguished inventor whose work in gene expression technologies has led to innovative patents that enhance our understanding of gene regulation. His contributions continue to impact the field significantly.